A new formulation of the COMIRNATY booster "12 years of age and older, Ready
to use (Original/Omicron BA.1 Cap and Package, Multi-dose vial)" was approved
on DD/MM/YY with procedure X/0000.Additional website content relevant to this
new formulation will be available on DD/MM/YY.

COMIRNATY Original/Omicron BA.1 15/15 micrograms/per dose for dispersion
for injection, for 12 years of age and older, Ready to use (Original/Omicron BA.1
Cap and Package, Multi-dose vial)
PP-CMR-GLB-0188

Este sitio está destinado a profesionales de la salud.

TERMS OF USE - COMIRNATY
  1. Use and content of this Web site. The information provided on this site is for general informational and educational purposes and has been approved by relevant regulatory authorities.

    Certain sections of this Web site are intended for Healthcare Professionals only and we ask you to not access these sections if you are not a Healthcare Professional. Specific appropriate sections have been developed and are accessible for the general public. Your access to and use of the information contained in the Web site is subject to this Terms of Use Agreement. By accessing and using this Web site, you accept, without limitation or qualification, this Terms of Use Agreement.
    Neither Pfizer nor any party involved in creating, producing or delivering this Web site shall be liable for any damages, including without limitation, direct, incidental, consequential, indirect or punitive damages, arising out of access to, use of or inability to use this Web site, or any errors or omissions in the content thereof. This limitation includes damages to, or for any viruses that infect, your computer equipment.

  2. Privacy. Pfizer respects the privacy of its Web site users. Please refer to https://privacycenter.pfizer.com/ that explains users' rights and responsibilities with respect to information that is disclosed on this Web site.

  3. Third Party Web sites and Links. This Web site may contain links or references to other Web sites maintained by third parties over whom Pfizer has no control. Such links are provided merely as a convenience. Similarly, this Web site may be accessed from third party links over whom Pfizer has no control. Pfizer makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any information contained in such Web sites and shall have no liability for any damages or injuries of any kind arising from such content or information. Inclusion of any third party link does not imply an endorsement or recommendation by Pfizer.

  4. Medical Information. Patients should not use the information contained in this website for diagnosing a health or fitness problem or disease. Patients should always consult with a doctor or other health care professional for medical advice or information about diagnosis and treatment.

  5. Non-Confidential Information. Subject to any applicable terms and conditions set forth in our Privacy Policy, any communication or other material that you send to us through the Internet or post on a Pfizer Web site by electronic mail or otherwise, such as any questions, comments, suggestions or the like, is and will be deemed to be non-confidential and Pfizer shall have no obligation of any kind with respect to such information. Pfizer shall be free to use any ideas, concepts, know-how or techniques contained in such communication for any purpose whatsoever, including but not limited to, developing, manufacturing and marketing products.

  6. Trademarks. All product names, whether or not appearing in large print or with the trademark symbol, are trademarks of Pfizer, its affiliates, related companies or its licensors or joint venture partners, unless otherwise noted. The use or misuse of these trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, the law of slander and libel, the law of privacy and publicity, and communications regulations and statutes. Please be advised that Pfizer actively and aggressively enforces its intellectual property rights to the fullest extent of the law.

  7. Copyrights. The entire contents of this Web site are subject to copyright protection. Copyright © 2020 Pfizer Inc. The contents of Pfizer Web sites may not be copied other than for non commercial individual reference with all copyright or other proprietary notices retained, and thereafter may not be recopied, reproduced or otherwise redistributed. Except as expressly provided in the website or above, you may not otherwise copy, display, download, distribute, modify, reproduce, republish or retransmit any information, text or documents contained in this Web site or any portion thereof in any electronic medium or in hard copy, or create any derivative work based on such images, text or documents, without the express written consent of Pfizer. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent or trademark of Pfizer, or any third party.

  8. Void Where Prohibited. This Web site and its contents are intended to comply with the laws and regulations in the E.U. Although the information on this Web site is accessible to users outside of the E.U., the information contained on this website is intended for use only by residents of the E.U. Other countries may have laws, regulatory requirements and medical practices that differ from those in the E.U. Pfizer reserves the right to limit provision of its products or services to any person, geographic region or jurisdiction and/or to limit the quantities or any products or services we provide. Any offer for any product or service made on this Web site is void where prohibited.

  9. Governing Laws. This Terms of Use Agreement and your use of the Web site shall be governed by the laws of Belgium without regard to its conflicts of laws principles. Any legal action or proceeding related to this Web site shall be brought exclusively in a federal or state court of competent jurisdiction sitting in Belgium.

  10. Miscellaneous. If any provision of this Agreement is held to be unlawful, void or unenforceable, then such provision shall be severable without affecting the enforceability of all remaining provisions. Pfizer reserves the right to alter or delete materials from this Web site at any time at its discretion.

Para obtener información médica en Chile

 +56 2 22412035

Contact

Actualizaciones de la hoja informativa de EUA

Tenga en cuenta que la vacuna Pfizer-BioNTech COVID-19 ahora está disponible en 8 formulaciones. Para obtener información adicional sobre las diferencias entre grupos de edad y formulaciones, consulte la Guía de formulaciones de vacunas en la página de inicio de este sitio web.

Actualización de la etiqueta: a partir de Diciembre de 2023

Actualización de la vida útil para las siguientes formulaciones;

- 12 años y mayores: No diluir, Omicron XBB.1.5, tapa gris
- 12 años y mayores: No diluir, Original/Omicron BA.4/BA.5, tapa gris
- 12 años y mayores: No diluir, Original/Omicron BA.1, tapa gris
- 12 años y mayores: No diluir, tapa gris
- 12 años y mayores: Diluir antes de usar, tapa morada
- 5 a 11 años: Diluir antes de usar, tapa naranja
- 5 a 11 años: Diluir antes de usar, Original/Omicron BA.4/BA.5, tapa naranja
- 6 meses a menores de 5 años: Diluir antes de usar, tapa granate

Para más detalle consulte la Guía de formulaciones de vacunas en la página de inicio de este sitio web.

Información reservada a profesional de la salud

                 ¿Es usted un profesional de salud certificado?